The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy

Chronic hepatitis C virus (HCV) infection places a considerable economic burden on health services. Cost-effectiveness analyses of antiviral treatment for patients with chronic HCV infection are dependent on assumptions about cost reductions following sustained virological response (SVR) to therapy....

Full description

Bibliographic Details
Main Authors: Backx, M., Lewszuk, A., White, J.R., Cole, J., Sreedharan, A., van Sanden, S., Diels, J., Lawson, A., Neal, K.R., Wiselka, M.J., Ito, T., Irving, William L.
Format: Article
Published: Wiley 2014
Subjects:
Antiviral therapy
Chronic viral hepatitis
Cost-effectiveness
Health economics
Hepatitis C
Online Access:https://eprints.nottingham.ac.uk/35706/

Internet

https://eprints.nottingham.ac.uk/35706/

Similar Items